Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2012
06/20/2012EP2465535A1 Methods for treating conditions associated with MASP-2 dependent complement activation
06/20/2012EP2465534A1 Methods for treating conditions associated with MASP-2 dependent complement activation
06/20/2012EP2465533A1 Methods and compositions comprising supramolecular constructs
06/20/2012EP2465532A1 JC virus vaccine
06/20/2012EP2465531A1 Apoptosis-inducing polypeptides
06/20/2012EP2465530A1 Multivalent entrain-and-amplify immunotherapeutics for carcinoma
06/20/2012EP2465529A2 Educated NKT cells and their uses in the treatment of immune-related disorders.
06/20/2012EP2465528A2 Educated NKT cells and their uses in the treatment of immune-related disorders.
06/20/2012EP2465527A2 Educated NKT cells and their uses in the treatment of immune-related disorders.
06/20/2012EP2465526A2 Educated NKT cells and their uses in the treatment of immune-related disorders.
06/20/2012EP2465525A2 Educated NKT cells and their uses in the treatment of immune-related disorders.
06/20/2012EP2465524A1 Autoantibody production inhibitor
06/20/2012EP2465520A2 Epitope sequences
06/20/2012EP2464665A1 Human monoclonal antibody against s. aureus derived alpha-toxin and its use in treating or preventing abscess formation
06/20/2012EP2464664A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use
06/20/2012EP2464658A1 Detoxified escherichia coli immunogens
06/20/2012EP2464388A1 Particulate hyaluronic acid formulations for cellular delivery of bioactive agents
06/20/2012EP2464383A2 Compositions and methods for the therapy and diagnosis of influenza
06/20/2012EP2464382A1 Combination therapy of an afucosylated cd20 antibody with bendamustine
06/20/2012EP2464381A1 Anti-angiogenesis therapy for the treatment of previously treated breast cancer
06/20/2012EP2464380A1 Combination therapy of an afucosylated cd20 antibody with fludarabine and/or mitoxantrone
06/20/2012EP2464379A1 Vaccine having a peptide adjuvant for eliciting a specific immune response to treat viral infection and other conditions
06/20/2012EP2464378A1 Use of mycobacterium bovis bcg killed by extended freeze drying (efd) for preventing or treating atherosclerosis
06/20/2012EP2464343A1 Ophthalmic drug delivery system containing phospholipid and cholesterol
06/20/2012EP2464341A2 Immunomodulatory compositions comprising a polymer matrix and an oil phase
06/20/2012EP2364731A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2359855A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2181189B1 Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use
06/20/2012EP2129394B1 Papillomavirus vaccine compositions
06/20/2012EP2075258B1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same
06/20/2012EP1858548B1 Compositions of hsp60 peptides and viral antigens for vaccination and diagnosis
06/20/2012EP1810979B1 STABILIZED HUMAN IgG4 ANTIBODIES
06/20/2012EP1735348B1 Human anti-epidermal growth factor receptor antibody
06/20/2012EP1691837B1 Ip-10 antibodies and their uses
06/20/2012EP1546203B1 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
06/20/2012EP1527080B1 Campylobacter glycans and glycopeptides
06/20/2012EP1452541B1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
06/20/2012EP1311267B1 A retroviral immunotherapy
06/20/2012EP1252182B1 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA
06/20/2012EP1240315B1 Cloning of a gene encoding an amino acid racemase from trypanosoma cruzi, and uses thereof
06/20/2012CN1942201B Methods of modulating cytokine activity, related reagents
06/20/2012CN1906214B Anti-IGFR1 antibody therapeutic combinations
06/20/2012CN1550236B Protein stability in aqueous solution
06/20/2012CN102504042A Method for removing endotoxin from bacteria capsular polysaccharide
06/20/2012CN102504026A Full human single chain antibody capable of resisting epidermal growth-factor receptor and application thereof
06/20/2012CN102504025A Estrogen receptors and methods of use
06/20/2012CN102504024A Antibodies that bind human interleukin-18 and methods of making and using
06/20/2012CN102504023A Method for preparing egg yolk antibody, egg yolk antibody prepared by method and application of egg yolk antibody
06/20/2012CN102504016A Amyloid fibrillar oligomer conformational epitope polypeptide and application thereof
06/20/2012CN102499984A Method of treatment and bioassay involving macrophage migration inhibitory factor (mif) as cardiac-derived myocardial depressant factor
06/20/2012CN102499983A Application of HepG2.2.15 cell autophagy corpuscle in preparing hepatitis b virus (HBV) therapeutic vaccines
06/20/2012CN102499982A Method for producing trivalent inactivated vaccine against Haemophilus parasuis infection
06/20/2012CN102499179A Method for establishing rat model with IgAN (immunoglobulin A nephropathy) glomerulosclerosis
06/20/2012CN102499177A Application of IgAN glomerular sclerosis rat model
06/20/2012CN101988067B Prion isomer monoclonal antibody gene and application thereof
06/20/2012CN101862452B Method for preparing swine multi-valent antiserum compound preparation
06/20/2012CN101850115B Method for producing swine fever live vaccine by using porcine kidney cell line (IBRS-2) and product thereof
06/20/2012CN101602808B Specific binding protein and application thereof
06/20/2012CN101518556B Polysaccharide with antitumor and immunologic adjuvant function as well as preparation method and purpose thereof
06/20/2012CN101426526B Solution phase biopanning method using engineered decoy proteins
06/20/2012CN101282743B Bacteriocin and novel bacterium mycopremna
06/20/2012CN101052418B Use of bacterial endotoxin antibody in preparing medicine for treating rheumatoid arthritis
06/19/2012US8202977 Pestivirus species
06/19/2012US8202969 Platelet derived growth factor receptor alpha (PDGFRA) polypeptides comprising activating mutation(s)
06/19/2012US8202967 H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
06/19/2012US8202850 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
06/19/2012US8202847 Mutant human CD80 and compositions for and methods of making and using the same
06/19/2012US8202717 Non-simian cells for growth of porcine reproductive and respiratory syndrome (PRRS) virus
06/19/2012US8202688 Synergistic mixtures; hepatitis virus
06/19/2012US8202523 Glycosylated polypeptides produced in yeast mutants and methods of use thereof
06/19/2012US8202522 Skin cosmesis treatment with clostridia neurotoxins
06/19/2012US8202521 Methods and compositions for poxvirus lacking A35R protein
06/19/2012US8202520 Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
06/19/2012US8202518 Antibodies against human cytomegalovirus (HCMV)
06/19/2012US8202514 Bacillus subtilis strain having antagonistic activity for controlling plant diseases
06/19/2012US8202513 Aryl potassium channel blockers and uses thereof
06/19/2012CA2599754C Use of interleukin 17e for the treatment of cancer
06/19/2012CA2519806C Composition comprising iscom particles and live micro-organisms
06/19/2012CA2478012C Internalizing anti-cd74 antibodies and methods of use
06/19/2012CA2422538C Notch receptor agonists and uses
06/19/2012CA2393975C Insect poison allergens with reduced ige reactivity and method for producing the same
06/19/2012CA2311166C Nucleic acids involved in the responder phenotype and applications thereof
06/14/2012WO2012079093A2 Dosage and administration of bispecific scfv conjugates
06/14/2012WO2012079000A1 Use of chimeric antigen receptor-modified t cells to treat cancer
06/14/2012WO2012078813A2 Novel modulators and methods of use
06/14/2012WO2012078771A1 Treatment of her2-positive cancer with paclitaxel and trastuzumab-mcc-dm1
06/14/2012WO2012078761A2 Dimeric molecular complexes with free cysteine residues and conjugates thereof
06/14/2012WO2012078688A2 Humanized antibodies to liv-1 and use of same to treat cancer
06/14/2012WO2012078633A2 Methods of inhibiting metastasis from cancer
06/14/2012WO2012078484A1 Compositions and methods for vaccinating cattle
06/14/2012WO2012078014A1 Recombinant single-chain antibody fragment neutralizing the cytolytic activity of vaginolysin
06/14/2012WO2012077649A1 Human monoclonal antibody
06/14/2012WO2012077076A1 Treating or preventing sensitivity to milk allergens
06/14/2012WO2012076883A1 Anti ccr4 antibodies and uses thereof
06/14/2012WO2012076868A1 Antibodies to mycobacteria
06/14/2012WO2012076846A1 Polymorphism
06/14/2012WO2012076727A1 Antibodies against ror1 and uses thereof
06/14/2012WO2012076688A1 Combination comprising a derivative of the family of the combretastatins and cetuximab
06/14/2012WO2012076670A2 Antibody formulation
06/14/2012WO2012076668A1 Strongly inactivated and still highly immunogenic vaccine and process of manufacturing thereof
1 ... 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 ... 1823